FDA approves Pfizer’s biosimilar to Roche’s Herceptin
FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018. REUTERS/Arnd Wiegmann (Reuters) – The U.S. Food and Drug…
U.S. says rejects WTO’s ‘straitjacket’ of trade obligations
WASHINGTON (Reuters) – The Trump administration filed another salvo at the World Trade Organization on Friday, saying U.S. trade policy was not going to be dictated by the international body…
German carmakers to invest 60 billion euros in electric cars and automation: VDA
FILE PHOTO – Electric car is charged at the charging station at the front of the German utility E.ON headquarters in Essen, Germany, May 9, 2018. REUTERS/Wolfgang Rattay FRANKFURT (Reuters)…
New cancer-causing toxin found in recalled blood pressure pills
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled by India’s Hetero Labs Ltd a day earlier, adding to…
Novartis gene therapy would be cost effective up to $900,000: U.S. group
(Reuters) – An experimental gene therapy for spinal muscular atrophy (SMA) developed by Swiss drugmaker Novartis AG would be worth a price of $310,000 to $900,000, according to an independent…
Venezuela crisis could spark surge in infectious diseases: study
FILE PHOTO: A Venezuelan health worker fumigates the Valle slum to help control the spread of the mosquito-borne Zika virus in Caracas, January 28, 2016. REUTERS/Marco Bello/File Photo LONDON (Reuters)…
Bruno Ganz, Who Played Adolf Hitler In ‘Downfall,’ Dead At 77
ZURICH, Feb 16 (Reuters) – Bruno Ganz, the Swiss actor who portrayed Adolf Hitler in Oscar-nominated film “Downfall” and the kindly grandfather in “Heidi,” died of cancer at his home…
France suggests glyphosate exit could be even slower than planned
PARIS (Reuters) – Only half of France’s farmland could do without glyphosate-based weed-killers by 2021, the country’s farm minister suggested, further lowering an initial ambition to get rid of the…
Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva
NEW YORK (Reuters) – A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as…
FDA approves cheaper Botox rival to treat frown lines
(Reuters) – An injection that makes forehead wrinkles disappear is set to rival Allergan’s Botox after U.S. regulators approved Evolus Inc’s cheaper treatment on Friday. Evolus expects Jeuveau to be…